I am an assistant attending physicist in the Department of Medical Physics with board certification in Nuclear Medical Physics. My responsibilities include performing quality assurance procedures and providing clinical support for gamma cameras in the Molecular Imaging and Therapy Service at Memorial Sloan Kettering.
My involvement in several multidisciplinary teams at our institution has allowed me to gain experience in the following research areas: pharmacokinetic modeling of novel radiotracers (e.g., surrogate biomarkers of tumor hypoxia, glutamine flux and metabolism, norepinephrine transporter activity, inhibition of heat shock protein 90, and expression of programmed death-ligand 1); imaging and assessment of response to targeted therapies; radionuclide dosimetry; and techniques to quantify and improve drug delivery.
I am also a member of the National Institutes of Health’s Quantitative Imaging Network.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Milan Grkovski discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures